GitLab Cl A had its Relative Strength (RS) Rating upgraded from 68 to 74 Tuesday — a welcome improvement, but still below the 80 or higher score you look for.
IBD's unique RS Rating measures technical performance by using a 1 (worst) to 99 (best) score that identifies how a stock's price performance over the last 52 weeks stacks up against all the other stocks in our database.
Decades of market research shows that the best stocks often have an RS Rating north of 80 as they launch their biggest climbs. See if GitLab Cl A can continue to rebound and clear that threshold.
When To Sell Stocks To Lock In Profits And Minimize Losses
GitLab Cl A is not currently showing a potential entry point. See if the stock goes on to form a base that could launch a new move.
Earnings growth moved up in the company's most recent report from 0% to 1,400%, but revenue fell from 33% to 31%. The company is expected to report its latest earnings and sales numbers on or around Dec. 2.
GitLab Cl A holds the No. 5 rank among its peers in the Computer-Technical Services industry group. CACI International Cl A is the No. 1-ranked stock within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
